MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
Exploring Early Brain Development Through Music, Speech and MEG | Dr. Christina Zhao

Exploring Early Brain Development Through Music, Speech and MEG | Dr. Christina Zhao

by Naomi Devlin | Sep 22, 2026 | Spotlights - Translational Research

MEGIN Spotlights Exploring Early Brain Development Through Music, Speech and MEG | Dr. Christina Zhao In this MEGIN Spotlight, we welcome Dr. Christina Zhao, Director of the Lab for Early Auditory Perception (LEAP) within the Institute for Learning and Brain Sciences...
MEGIN Matters September 2026

MEGIN Matters September 2026

by Naomi Devlin | Sep 10, 2026 | MEGIN Matters

MEGIN Launches Side-by-Side Dual-MEG Hyperscanning Facility at Tsinghua University

MEGIN Launches Side-by-Side Dual-MEG Hyperscanning Facility at Tsinghua University

by Naomi Devlin | Jul 8, 2026 | MEGIN News

MEGIN Launches Side-by-Side Dual-MEG Hyperscanning Facility at Tsinghua University by MEGIN | July 8, 2026 | MEGIN news Two whole-head MEG systems sit side by side, giving researchers a real-time window into how two brains interact during natural conversation,...
MEGIN Matters June 2026

MEGIN Matters June 2026

by Naomi Devlin | Jul 7, 2026 | MEGIN Matters

MEGIN Matters May 2026

MEGIN Matters May 2026

by Naomi Devlin | Jul 7, 2026 | MEGIN Matters

« Older Entries

Home
About us

MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.